Tune in for this insightful podcast with David Weinstock, the Vice President of Discovery Oncology at Merck, to find out what pharma investors really think when they are interviewing startups looking for funding.
How a pharma looks at partnering with a startup, versus how a VC does
What a pharma loves and hates hearing – less salesmanship, more data
Why asking them to sign an NDA is not as savvy as you think
How to make the most effective deck
Why the financial projections in a deck make his eyes roll
What he looks for in a founder’s pitch
Enjoy the show!
Disclaimer
The information contained in this website and podcast are purely informational and not considered investment recommendations. Tim Dougherty’s participation in Biotech Insights is separate and apart from his role as an investment advisor representative. Nothing contained herein may be construed as a recommendation or endorsement of any of the companies discussed. Tim Dougherty has no financial affiliation with any of the companies mentioned in this communication. Tim Dougherty makes no representation that the information conveyed in this material is accurate and is under no obligation to update this information as changes occur.
Comments